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Abstract
AID/APOBEC family cytosine deaminases, known to function in diverse cellular processes from 
antibody diversification to mRNA editing, have also been implicated in DNA demethylation, an 
important process for transcriptional activation. While oxidation-dependent pathways for 
demethylation have been described, pathways involving deamination of either 5-methylcytosine 
(mC) or 5-hydroxymethylcytosine (hmC) have emerged as alternatives. Here, we have addressed 
the biochemical plausibility of deamination-coupled demethylation. We found that purified AID/
APOBECs have substantially reduced activity on mC relative to cytosine, their canonical 
substrate, and no detectable deamination of hmC. This finding was explained by the reactivity of a 
series of modified substrates, where steric bulk was increasingly detrimental to deamination. 
Further, upon AID/APOBEC overexpression, the deamination product of hmC was undetectable 
in genomic DNA, while oxidation intermediates remained detectable. Our results indicate that the 
steric requirements for cytosine deamination are one intrinsic barrier to the proposed function of 
deaminases in DNA demethylation.
AID/APOBEC enzymes are well characterized for their ability to deaminate cytosine to 
uracil. In various cellular settings, this modification alters and expands the genome’s coding 
potential1, 2. In the immunoglobulin locus of the maturing B cell, activation-induced 
deaminase (AID) deaminates cytosine to trigger pathways that facilitate antibody affinity 
maturation or isotype switching. Similarly, APOBEC3 enzymes extensively hypermutate 
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reverse-transcribed DNA as a powerful innate defense mechanism to antagonize retroviruses 
and retroelements. Finally, APOBEC1 deaminates cytosine to introduce a stop codon in the 
mRNA of an apolipoprotein, generating a protein variant that differentially influences lipid 
metabolism. In each of these canonical functions, the purposeful mutations achieved by 
AID/APOBEC enzymes are generated by the deamination of a canonical cytosine 
nucleobase in RNA or DNA (Fig. 1). However, the role of modified cytosine bases in 
epigenetic regulation of gene expression raises the pressing question as to whether these 
enzymes can also act on non-canonical 5-substituted cytosines1, 3, 4.
The best understood cytosine modification is 5-methylcytosine (mC), which exerts 
transcriptionally repressive effects that are integral to such processes as genomic imprinting, 
X-chromosome inactivation, cellular differentiation and response to signaling stimuli5. This 
epigenetic modification is achieved through the action of DNA methyltransferase enzymes 
in mammalian cells, which introduce and maintain the methylation mark on the C5-position 
of cytosine bases within CpG motifs. An added layer of chemical complexity has emerged 
with the recent observation that mC is oxidized to 5-hydroxymethylcytosine (hmC) by the 
TET family of Fe(II)/α-ketoglutarate dependent oxygenase enzymes6, 7, though the 
consequences of hmC on gene expression are only starting to be elucidated8–10.
To achieve DNA demethylation – an important process for reversing cytosine methylation 
and restoring transcription – cytosine deamination, oxidation, and base excision repair 
(BER) have been invoked in a variety of possible combinations (Fig. 1)1, 11, 12. In this 
regard, two types of deamination-dependent mechanisms have been postulated. In one 
scenario, deamination of mC by an AID/APOBEC enzyme generates a T:G mismatch 
leading to subsequent repair by the BER enzyme thymidine DNA glycosylase (TDG)13. In 
the other scenario, deamination of hmC generates 5-hydroxymethyluracil (hmU), which 
could also be reverted to cytosine by BER14. Recent studies have also demonstrated the 
feasibility of a deamination-independent pathway for DNA demethylation involving 
oxidation of mC by TET enzymes. The product of this oxidation, hmC, undergoes iterative 
oxidation to yield both 5-formylcytosine (fC) and 5-carboxylcytosine (caC)15, 16. These 
higher oxidation products are detectable in the genome of embryonic stem cells and are 
good substrates for excision by TDG, which could ultimately regenerate unmodified 
cytosine15–19. Notably, deficiency in TDG, a potential common mediator in the various 
proposed pathways for DNA demethylation, is associated with developmental methylation 
defects and embryonic lethality20, 21.
The plausibility of deamination-dependent demethylation has been difficult to establish 
because of the poorly characterized activities of AID/APOBEC enzymes on C5-modified 
cytosines and a lack of knowledge about the functional redundancy between AID/APOBEC 
family members22. Although prior studies suggest that AID can deaminate mC at reduced 
levels relative to cytosine13, 23, other work proposes that the enzyme lacks any mC 
deaminase activity24. Additional ambiguity arises because the activities of other APOBEC 
enzymes on mC have not been directly investigated, and the biochemical activities of all 
AID/APOBECs against hmC remain entirely unknown.
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In general, the presence of numerous AID/APOBEC family members presents a challenge to 
sorting out their potential roles in demethylation. A potential role for AID in demethylation 
of pluripotency promoters arises from heterokaryon-based systems for the generation of 
stem cells25, and the suggestion that AID deficiency perturbs the DNA methylome of 
primordial germ cells26. However, these observations are confounded by the finding that 
AID deficiency is viable 27, suggesting that other deaminases might serve functionally 
redundant roles in demethylation. In support of this proposal, APOBEC2 enzymes are 
postulated to play a role in zebrafish DNA demethylation28 and APOBEC1 is implicated in 
neuronal DNA demethylation14. Thus, biochemical characterization of the similarities and 
differences between these deaminases would address the functional redundancy of these 
enzymes in DNA demethylation.
The previous implications that deaminases might be involved in DNA demethylation1, 3, 4 
make it important to examine their activity on 5-substituted cytosine bases in DNA. Here, 
we have elucidated the substrate preferences of AID/APOBEC family members and 
examined the plausibility of deamination-dependent versus oxidation-dependent pathways 
for cytosine demethylation. We found that all AID/APOBEC family members preferentially 
deaminate unmodified cytosine and strongly discriminate against 5-substituted cytosine 
substrates with increasing steric bulk. We also observed these preferences in cells, where the 
deamination products of the bulky base hmC are not detected when deaminases are 
overexpressed. Further, intermediates in the iterative oxidation pathway were readily found 
in genomic DNA, and their formation was not diminished by the overexpression of 
deaminases. We argue that, relative to the oxidation-mediated pathway, the potential for 
function of deaminases in DNA demethylation is limited.
Results
AID/APOBECs preferentially deaminate unmodified cytosine
We wished to profile the reactivity of representative AID/APOBEC family members with 
modified cytosine nucleobases. We chose to investigate the mouse enzyme family, which 
possesses only a single gene for each family member (Supplementary Results, 
Supplementary Fig. 1a), rather than the human family, where extensive gene duplication and 
specialization at the A3 locus have generated at least seven A3A-A3H variants. Mouse 
APOBEC1 (mA1), APOBEC2 (mA2), APOBEC3 (mA3) and AID (mAID) were generated 
as N-terminal maltose binding protein fusion constructs. Although mAID was inactive under 
these conditions (data not shown), we had previously expressed and characterized active 
human AID (hAID) by co-expression of the enzyme with the chaperone Trigger Factor in E. 
coli29. Using this expression system, the expanded cohort of AID/APOBEC enzymes were 
all soluble and were partially purified over amylose resin (Supplementary Methods, 
Supplementary Fig. 1b).
We designed DNA oligonucleotides containing a single cytosine residue with several criteria 
in mind. First, since each AID/APOBEC family member prefers to deaminate cytosine in a 
different trinucleotide sequence context29–31, we selected a universal sequence that would 
be acted upon by multiple family members (S30-TGC). Next, a guanine was introduced 
directly downstream of the cytosine to create a CpG motif, an important consideration given 
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that epigenetic modifications via methylation, hydroxymethylation and demethylation are 
highly linked to CpG sites and islands in the mammalian genome. All oligonucleotides were 
synthesized using standard phosphoramidite chemistry (Supplementary Methods).
AID/APOBEC family members were assayed against the cytosine-containing substrate S30-
TGC using a discontinuous, uracil DNA glycosylase(UDG)-coupled assay (Fig. 2a). At the 
end of the deamination period, the reaction product was hybridized to a complementary 
strand, yielding duplexed DNA containing a U:G mismatch in the deaminated product. 
Treatment with UDG generated abasic sites in the deaminated oligonucleotides, while 
leaving unreacted substrates intact. Cleavage of the abasic sites under alkaline conditions 
allowed for specific detection of product after separation on a denaturing gel. Under these 
conditions the mA1, mA3 and hAID variants all showed deaminase activity against S30-
TGC (Fig. 2b and Supplementary Fig. 2). As anticipated from prior studies mA2 showed no 
detectable cytosine deaminase activity32.
To next examine the deamination activities on physiologically relevant 5-modified 
cytosines, we synthesized S30-TGmC and S30-TGhmC. Upon deamination, these target 
bases would convert to T and hmU, respectively. Alternate DNA glycosylases were used to 
detect these species: TDG, which excises thymidine from T:G mismatches in CpG contexts, 
and human SMUG1 (SMUG), which excises hmU mispaired to G (Fig. 2a). We established 
that these glycosylase-coupled assays accurately detect low levels of deamination products 
(as little as 0.5% product under the condition of our deamination reaction) (Supplementary 
Fig. 3). Using the TDG-coupled assay, deamination of S30-TGmC was detectable with all 
active AID/APOBEC enzymes, though product formation was decreased relative to S30-
TGC (Fig. 2b). By contrast, no detectable deamination activity was evident against S30-
TGhmC, despite robust deamination of S30-TGC under identical conditions with mA1, mA3 
and hAID. mA2 was also inactive against both S30-TGmC and S30-TGhmC in vitro.
To assure that the discrimination against 5-substituted cytosine bases was not simply limited 
to a single sequence context, or perhaps the single enzyme concentration used in the above 
studies, we performed additional investigations. First, we tested a series of substrates 
containing C, mC and hmC in an ATX trinucleotide context, which is a preferred sequence 
for mA1. As expected, reaction of S30-ATC with mA1 led to robust deamination, while 
S30-ATmC was compromised and deamination of S30-AThmC was undetectable (Fig, 2c). 
With varying concentrations of mA1, deamination was linearly dependent on the amount of 
enzyme used. mA1 was estimated to have ~10-fold discrimination against mC relative to 
unmodified C, and >300-fold discrimination against hmC based on our detection limits. We 
conducted similar enzyme-dependent analysis of deamination of S30-TGX substrates with a 
C-terminal truncation variant of hAID (hAID-ΔC), which is associated with hyperactive 
deamination (~3-fold) without impacting sequence-dependent targeting29. We reasoned that 
low-level deamination might be easier to detect with this hyperactive variant. As with mA1, 
a similar discrimination against mC (~16-fold) and significant discrimination against hmC 
(>150-fold) was found (Fig. 2c). A quantitatively similar pattern can be observed with full-
length hAID (Supplementary Fig. 4). Finally, mA3 also demonstrated clear discrimination 
against the naturally modified cytosine nucleobases (Supplementary Fig. 4). We conclude 
that discrimination against 5-substituted cytosines is an intrinsic property evident in the 
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entire AID/APOBEC enzyme family regardless of the source organism or canonical 
function.
Deamination decreases with increasing steric bulk at C5
The molecular basis for recognition of cytosine by AID/APOBEC enzymes is a matter of 
speculation given the lack of structural information on these enzymes complexed with 
nucleic acid substrates. To probe the molecular impact of substitution at the 5-position of 
cytosine, we synthesized additional substrates with unnatural 5-substituents of varied steric 
and electronic character (Fig. 3a) using a sequence context appropriate for hAID (S30-TGX) 
or mA1 (S30-ATX). One potential determinant of reactivity in this series is the electron 
withdrawing ability of the C5-substituents. Electronegative C5 groups could potentially 
enhance deamination by making C4 of cytosine more electrophilic or by lowering the pKa of 
N3. Alternatively, hydrophobicity of the 5-position substituent could influence selectivity33. 
Finally, the size of the substituent at the 5-position could dominate the rate effect.
In order to study deamination of these unnatural cytosines, we first determined the 
specificity of UDG, TDG and SMUG against DNA substrates containing either the modified 
cytosine or the corresponding 5-substituted uracil. Based on the determined substrate 
preferences, we selected UDG to assay the 5-fluoro substrates and SMUG for the 5-hydroxy, 
5-bromo and 5-iodo substrates (Supplementary Fig. 5). We also constructed standard curves 
to allow for accurate quantification of deamination of each unnatural 5-modified substrate 
using our glycosylase-coupled assay (Supplementary Fig. 6).
Each 5-substituted S30-TGX substrate was incubated with hAID-ΔC, then duplexed and 
treated with the appropriate glycosylase to assay for deamination. For hAID-ΔC, any 
substitution resulted in decreased efficiency of deamination relative to unmodified cytosine 
(Fig. 3b and Supplementary Fig, 7). To allow for relative comparison of substrates, we next 
calculated the product formation under conditions where deamination was linearly 
proportional to enzyme concentration. Across these series of substrates, representing a >150-
fold difference in reactivity, the size of the substituent at the 5-position appeared to be an 
important determinant of deamination (Fig. 3c and Supplementary Fig. 8). The smallest 
unnatural substituent, S30-TG(5F)C, was deaminated most readily, although it remained half 
as reactive as unmodified cytosine. Bulkier halogen substituents were relatively poor 
substrates compared to the smaller mC. In addition to the influence of sterics, the poor 
hydrophobic character of hmC may play an additional role in the reactivity decrease seen 
between (5I)C, which has detectable deamination, and hmC, which has no detectable 
deamination.
To assess the generality of reactivity determinants in the deaminase family, we additionally 
profiled mA1 against a series of unnatural substrates in its preferred S30-ATX context (Fig. 
3). Again, (5F)C was a good substrate for deamination, though approximately only one 
quarter as reactive as cytosine, while bulkier substituents were increasingly poor substrates 
(Fig. 3c). While smaller size remained a prerequisite for efficient deamination with mA1, 
hydrophobicity also appears to play an important role. This is most strikingly notable with 
(5OH)C, which undergoes negligible deamination, while the larger mC is readily 
deaminated. Our extensive data show that for two distinct, active APOBEC family enzymes, 
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efficient deamination of cytosine has steric requirements at the 5-position that contribute to 
the lack of any detectable enzymatic activity on hmC.
Deaminases do not alter global levels of epigenetic bases
Among the multiple potential pathways for DNA demethylation is the possibility of 
collaboration between oxidation and deamination to generate hmU from mC14. To 
complement our in vitro findings, we addressed whether hmC deamination could be detected 
in genomic DNA. Accordingly, we overexpressed one isoform of the TET oxidase family, 
TET2, in HEK 293T cells, the result of which generates a high prevalence of genomic hmC 
in a genome otherwise devoid of detectable oxidized cytosine bases15. TDG and the 
individual AID/APOBEC family members were co-transfected into HEK 293T cells along 
with TET2 to determine impact on modified nucleoside levels. Similar levels of expression 
for each enzyme were confirmed by Western blot (Supplementary Fig. 9). Using 
methodology we previously employed to detect the products of iterative oxidation by 
TET15, the genomic DNA was isolated and digested to generate a genomic nucleoside pool. 
For highly sensitive detection of the modified bases, the obtained nucleosides were 
subjected to LC-MS/MS in multiple reaction monitoring mode and quantified by 
comparison to known standards, including genomic cytosine to allow for approximation of 
the genomic prevalence of modified bases. This methodology enables detection of 10 fmol 
of hmU from 0.75 μg of genomic DNA, which converts to a detection limit of approximately 
2–3 hmU bases in 100,000 dC bases (Supplementary Fig. 10 and 11).
As has been previously observed, TET2 overexpression in isolation leads to hmC levels that 
are about 1/6 that of genomic mC. The products of iterative oxidation, fC and caC, can also 
be detected at about 1/100 the level of mC15, 16. We posited that if AID/APOBEC enzymes 
could deaminate hmC, three changes should be observed: hmU should be detected in 
genomic DNA, hmC levels should decrease, and fC/caC levels should also decrease due to 
the deamination of their precursor hmC. However, none of these three predicted changes 
were observed when TET2 was overexpressed along with either mA1 or hAID (Fig. 4a). In 
cells overexpressing TET2 and hAID or mA1, we conclude that the genome contains less 
than 2–3 hmU bases per 105 dC bases. To further examine whether other family members 
might influence the genomic levels of modified bases, we screened all mouse AID/APOBEC 
enzymes with similar results (Supplementary Fig. 11). To determine whether our inability to 
detect hmU could be due to its rapid enzymatic excision from the genome, we measured the 
hmU glycosylase activity from 293T nuclear extracts. We observed negligible hmU 
glycosylase activity under conditions where robust nuclear uracil glycosylase activity was 
observed (Supplementary Fig. 12). Together these data suggest that if deamination of hmC 
occurs, it falls below the detection limits of this sensitive methodology.
To confirm that the overexpressed deaminases were active despite the lack of detectable 
genomic hmU, we first examined nuclear lysates for deaminase activity using 
oligonucleotides containing unmodified cytosine. In line with our biochemical studies, 
deamination of cytosine was only detectable in nuclear lysates from cells overexpressing 
either hAID or mA1, but not a catalytic mutant of hAID (E58A) (Fig. 4b and Supplementary 
Fig. 13). As a second validation of deaminase activity in the cellular setting, we examined if 
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overexpressed deaminases have an appreciable impact on genomic deoxyuridine (dU) levels. 
To overcome the rapid and efficient processing of genomic dU by multiple DNA repair 
pathways, we inhibited the major pathway involving UDG by overexpressing the small 
protein uracil DNA glycosylase inhibitor (UGI) along with hAID, hAID-E58A, mA1 or an 
empty plasmid control (Supplementary Fig. 14). The nuclear lysates associated with UGI 
overexpression were unable to excise uracil from duplexed oligonucleotides, confirming that 
UGI effectively inhibited the major pathway for uracil excision. Notably, this observation 
also independently suggested low levels of TDG and SMUG activity in 293T cells, as low 
levels of uracil excision were seen despite the fact that these enzymes are not inhibited by 
UGI34. In these cells, we next quantified the level of genomic dU using our highly sensitive 
LC-MS/MS methodology and demonstrated a consistent increase in genomic dU in hAID 
samples relative to hAID-E58A or the empty plasmid control. Unlike hAID, it is unknown if 
mA1 can act upon genomic cytosine. In our analysis, mA1 overexpression also yielded 
increases in genomic dU levels compared to an empty vector control. Thus, by two 
measures, in lysates and analysis of genomic DNA, the deaminases were active on 
unmodified cytosine under conditions where no deamination of hmC was detectable.
By contrast to our results with overexpression of AID/APOBEC family members, we 
reasoned that if iterative oxidation coupled to BER is a feasible pathway for demethylation, 
levels of modified cytosine bases should be readily perturbed by co-expression of TET and 
TDG. Indeed, we found that TDG overexpression led to dramatic reductions in the highly 
oxidized fC and caC species. Interestingly, no overall change was observed in the levels of 
mC and hmC. While this observation could be explained by the sparsity of highly oxidized 
species relative to mC and hmC, it also suggests that TDG-mediated depletion of fC and caC 
does not promote further oxidation and consumption of genomic hmC. Potential 
explanations include the possibility that some genomic hmC is sheltered from further 
oxidation or plays roles independent of demethylation10. While the dynamics of iterative 
oxidation will require further intensive study, from our data we conclude that the global 
prevalence of modified cytosine nucleobases in the genome can be altered by 
overexpression of the players in the deamination-independent pathway, but not by those in 
the deamination-dependent pathway.
Discussion
The well-established roles of DNA deaminase enzymes in modulating the genome all 
involve deamination of unmodified cytosine: in antibody diversity (AID), retroviral 
restriction (A3) and RNA editing (A1). Here, we have considered the possibility that 
deaminases could also have a role in DNA demethylation via deamination of mC or hmC by 
assessing the ability of AID/APOBEC enzymes to deaminate modified forms of cytosine. 
Our observation that steric bulk of the 5-position substituent decreased the efficiency of 
deamination presents a mechanistic rationale for discrimination against mC and hmC. 
Although these enzymes have diverged to assume distinctive cellular functions, the 
consistent pattern of substrate selectivity across the AID/APOBEC family indicates a 
conserved active site architecture that is primarily tuned for the recognition and deamination 
of unmodified cytosine.
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Both steric and electronic effects of pyrimidine 5-substitutions are known to impact various 
enzymes that act on DNA. For the BER enzyme TDG, electron withdrawing effects from the 
C5-substituent promote nucleobase hydrolysis by weakening the N-glycosidic bond35. This 
finding fits nicely with its epigenetic role in removing fC and caC from DNA, because these 
bases have 5-substituents that activate cleavage of the glycosidic bond17. By contrast, steric 
exclusion of 5-substituents is important for the BER glycosylase UDG which uses a tyrosine 
side chain to selectively exclude thymidine and excise uracil with high proficiency36. It will 
be intriguing to see if structural studies on the AID/APOBEC enzymes in complex with 
DNA will demonstrate a similar molecular mechanism for discrimination against bulky 5-
position substituents on cytosine.
We can now reconcile the known characteristics of AID/APOBEC enzymes with their 
proposed function in DNA demethylation by examining the multiple levels of targeting 
involved in deamination. At the level of the nucleobase, our results suggest that deaminase 
enzymes have all evolved an active site that is designed to deaminate unmodified cytosine 
preferentially. However, deamination of mC to T can occur, albeit at ~10-fold reduced rate 
relative to cytosine deamination. Thus, strictly from the perspective of biochemical 
feasibility, deamination of mC may constitute a viable pathway for demethylation in some 
situations, though other constraints are important to consider (see below). By contrast, we 
demonstrated that deamination of hmC was not detectable in vitro nor in cells when relevant 
enzymes were overexpressed. Our results contrast with those of a prior study that used 
immunoblotting of DNA, a method of uncertain specificity, to report detection of genomic 
hmU37. However, our findings are in good agreement with studies on embryonic stem cells, 
where hmU is not detectable in genomic DNA when probed with a sensitive and specific 
mass spectrometry methodology18, 38, and with other groups who have not detected 
deamination of hmC by AID in vitro (personal communication, Svend Petersen-Mahrt). 
Together, our biochemical and cellular data provide a strong argument against the proposed 
collaboration between oxidation, deamination and BER as a pathway for DNA 
demethylation in mammalian cells.
Beyond the target cytosine, the local sequence context provides an additional potential 
barrier to efficient deamination. Each AID/APOBEC family member acts at preferred 
trinucleotide hotspots29–31, 39 (Supplementary Fig. 1a), yet methylated CpG motifs can be 
found in all common sequence contexts, even those that may be disfavored by the individual 
deaminases. Further, since all known AID/APOBEC enzymes are specific for single-
stranded DNA23, 40, it remains unclear how methylated CpG motifs in genomic DNA might 
be sufficiently targeted by AID/APOBECs. Although transcription or replication could 
generate single-stranded DNA, active demethylation of CpG islands does not always require 
replication or transcription41, 42. Further, only AID and human APOBEC3A have been 
shown to deaminate mammalian host genomic DNA43, 44, and these mutations appear to be 
localized to expressed genes. Finally, expression of the various deaminase family members 
is restricted to particular cell lineages, suggesting that a single deaminase is unlikely to play 
a universal role in demethylation.
Integrating across these layers of targeting, from the nucleobase to the cellular level, enables 
us to assess the plausibility of the early steps in the various proposed DNA demethylation 
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pathways. First, our findings show that deamination of mC remains a plausible 
demethylation pathway based on enzymatic function, although other known limitations in 
targeting would seem to present several barriers to its efficient function. It is possible that 
deamination of mC operates in non-physiological systems, such as heterokaryon-based 
reprogramming25. In other physiological settings, it will be important to examine whether 
these enzymes may play other niche roles21. Although our findings exclude hmC 
deamination as a detectable enzymatic activity, a requirement for AID/APOBEC enzymes in 
conversion of hmC to C in neurons has been suggested37. Notably, in that study, AID/
APOBEC enzymes were not shown to be directly capable of hmC deamination, and a 
requirement for catalytically active AID in conversion of hmC to C was also not established. 
If catalysis were to be required, it is feasible that AID/APOBEC-mediated deamination of C 
or mC indirectly stimulates TET or DNA damage response pathways to promote excision of 
genomic hmC. Our biochemical and cellular data make it unlikely that deamination of hmC 
by AID/APOBEC enzymes is involved in DNA demethylation. Finally, our data suggest that 
under the very same conditions where the product of hmC deamination (hmU) is below 
detectable limits, the proposed intermediates in the iterative-oxidation pathway, fC and caC, 
are readily detected. As we have addressed for the AID/APOBEC enzymes, this work raises 
the question of targeting by the TET enzymes. From their relative preferences for oxidation 
of mC, hmC and fC, to their regulated expression in the appropriate cellular settings, much 
remains to be understood. These questions form an important area of focus for further 
explorations on the mechanism of DNA demethylation.
Methods
AID/APOBEC Protein Expression and Purification
Expression vectors contained the mA1, mA2, and mA3 genes37 downstream of an N-
terminal maltose-binding protein (MBP) in pET41 (Novagen), as previously described for 
hAID29, and were generously provided by Junjie Guo and Hongjun Song (Johns Hopkins 
University). AID/APOBEC constructs were expressed and purified as described in 
Supplementary Methods.
Deamination Assays
Synthesis of oligonucleotides is detailed in Supplementary Methods. Deamination reactions 
were carried out in Buffer DA (20 mM Tris-Cl, pH 8.0, 1 mM dithiothreitol, 5 mM EDTA) 
with 0.1 μg/μL RNaseA, using 200 nM oligonucleotide substrate. Unless otherwise detailed, 
incubations were performed for 12 hours with 2 μM final enzyme concentration. Reactions 
with mA1 against AT-hotspot oligonucleotides were incubated for 15 min given higher 
overall catalytic activity. Reactions were incubated at 30 °C and terminated by 20 minutes at 
95 °C. Subsequently, excess complementary oligonucleotide was added (150 nM reaction 
oligonucleotide to 250 nM complement) and annealed by slow cooling from 95 °C. 
Duplexed DNA (final 100 nM) was incubated with the appropriate glycosylase using either 
0.25 units/μL UDG (New England Biolabs) or 140 nM hSMUG in 1 × Buffer DA with 0.1 
mg/mL BSA and incubated at 37 °C for 45 minutes. For TDG reactions, 1.6 μM TDG was 
used in 1 × Buffer DA supplemented with 0.1 mg/mL BSA, and reactions were incubated at 
16 °C for 12 hours. The selection of the glycosylase used was based upon comprehensive 
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survey of glycosylases (Supplementary Figure 5), selecting a glycosylase with robust 
activity against a given uracil analog, with no detectable activity on the associated cytosine 
analog. C and (5F)C substrates were assayed for deamination with UDG; mC substrates 
were assayed with TDG; and (5OH)C, (5Br)C, (5I)C and hmC were assayed with SMUG. 
The duration of the incubation times were selected to maximize the excision of the 
deaminated bases. DNA glycosylase reactions were quenched in 50% formamide (v/v) and 
150 mM NaOH and heated to 95 °C for 20 minutes to cleave the abasic sites generated by 
glycosylases.
Analysis of Deamination Assays
Reaction products were separated by denaturing PAGE (20% acrylamide/TBE/7M urea), run 
at 50°C and imaged on a Typhoon 9410 (Amersham Biosciences). The intensities of product 
and substrate bands were determined in QuantityOne (BioRad) after subtracting background 
intensities. To account for incomplete excision of deaminated bases, standard curves for 
quantifying the fraction of deaminated product were generated using S30-ATX substrates (X 
= C/mC/hmC) and S30-ATY products (Y = U/T/hmU), mixed in various ratios and treated 
with UDG (for C/U), SMUG (for hmC/hmU) or TDG (for mC/T). Identical conditions were 
used to generate standard curves with the unnaturally modified S30-TGX substrates and 
S30-TGY products, with UDG (for (5F)C/(5F)U) and SMUG (for (5OH)C/5(OH)U, (5Br)C/
(5Br)U and (5I)C/(5I)U). The calculated fraction of cleaved product was determined by the 
intensity of the fluorescent product over the total product plus substrate. For all deamination 
assays the actual fraction of deaminated product was determined with reference to the 
standard curve generated for the corresponding glycosylase (Supplementary Fig. 3 and 6).
Transient Expression of Candidate Enzymes
TDG, mA1 and mA3 from pCMV-SPORT6 vectors (Open Biosystems) were each cloned 
into a FLAG-tagged pcDNA3 vector (pcDNA3β-FLAG). mA2 amplified from mouse 
embryonic stem cell cDNA was cloned into pcDNA3β-FLAG. The cloned TET2 construct, 
untagged human AID and the catalytic mutant E58A of hAID were previously 
described15, 39. A synthetic gene encoding UGI was cloned into pIRESneo3 (Clontech). 
HEK 293T cells were transfected 18 hours after plating using Fugene HD transfection 
reagents (Roche) and harvested 48 hours after transfection. Additional details may be found 
in Supplementary Methods.
Mass spectrometric experiments
2.5 μg genomic DNA, isolated using the DNeasy Kit (Qiagen), was heat-denatured, 
hydrolyzed with 90 U of Nuclease S1 (Sigma) in Buffer (0.5 mM ZnSO4, 14 mM sodium 
acetate, pH 5.2) at 37 °C for 1 hour, followed by the addition of 5 μL 10 × Buffer 2 (560 
mM Tris-Cl, 30 mM NaCl, 10 mM MgCl2, pH 8.3), 0.5 μg of phosphodiesterase I 
(Worthington) and 2 U of Calf Intestinal Alkaline Phosphatase (New England Biolabs) for 
an additional 1 hour (final volume 50 μL). Digested DNA was then filtered with Nanosep3K 
(Pall Corporation) and 15 μL of filtered samples were subjected to LC-MS/MS analysis as 
described previously15 with an additional transition for hmU (m/z 259.0 to 125.0) and for 
dU (m/z 229.0 to 113.0). The absolute amount of nucleoside was quantified by comparison 
to known standards.
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Deamination and Base Excision Activity of Nuclear Lysates
Nuclear lysates were prepared from HEK 293T cells as previously described45. For analysis 
of deaminase activity, lysates (final protein concentration 0.3 μg/μL) were incubated with 
single-stranded oligonucleotide substrates (2 μM) in 1 × Buffer DA and 0.1 mg/μL BSA, for 
30 minutes. Reactions were quenched by addition of phenol:chloroform:isoamyl alcohol 
(25:24:1). Formamide and NaOH were added to DNA extracted from the aqueous phase 
(50% v/v, 150 mM final concentrations). Samples were processed and analyzed as described 
for deamination assays. For analysis of base excision activity against uracil or hmU in 
nuclear lysates, lysates (final concentration 0.2–0.3 μg/μL as detailed) were pre-incubated at 
37 °C for 20 minutes before addition of 1 μM duplex DNA. Reactions were quenched and 
analyzed as described above.
Statistical Analysis
All data shown represent the mean value for a given number of replicates, as specified in 
each figure legend. Error bars represent standard deviation from the mean. Student’s T-test 
determined statistical significance between groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Proposed non-canonical role for AID/APOBEC enzymes acting on modified cytosine 
substrates in DNA
(a) Deamination of cytosine plays known physiological roles in adaptive immunity (AID), 
innate immunity against retroviruses (APOBEC3 enzymes), and mRNA editing 
(APOBEC1). These canonical roles involve deamination of cytosine to generate uracil. (b) 
By contrast, the proposed function of AID/APOBEC family members on modified cytosine 
residues remains poorly understood despite their implication in potential pathways for active 
DNA demethylation. (c) Proposed pathways for DNA demethylation. Deamination of 5-
methylcytosine (mC) or 5-hydroxymethylcytosine (hmC), the product of TET-mediated 
oxidation, could generate thymidine or 5-hydroxymethyluracil (hmU), respectively. Base 
excision repair (BER) could subsequently excise the deaminated bases and replace them 
with unmodified cytosine. An alternative deamination-independent pathway involves 
iterative oxidation, generating 5-formylcytosine (fC) or 5-carboxylcytosine (caC). BER-
mediated excision of the oxidized cytosine would result in reversion to unmodified cytosine.
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Figure 2. AID/APOBEC enzymes preferentially deaminate unmodified cytosine
(a) Fluorophore(FAM)-labeled oligonucleotides (S30) synthesized with a single internal 
modified cytosine (red) embedded in a CpG motif were incubated with AID/APOBEC 
family members. After incubation, oligonucleotides were duplexed with a complementary 
strand generating U:G, T:G, or hmU:G mismatches with the deaminated substrates 
(blue).Treatment with UDG (reactive with U:G), TDG (reactive with T:G) or SMUG 
(reactive with hmU:G), respectively, followed by base-mediated cleavage fragments the 
deaminated products to a 15-mer (P15). (b) The reaction products resulting from incubation 
of S30-TGX substrates with mA1, mA2, mA3 or hAID are shown separated on a denaturing 
gel. The substrate and product controls, without incubation with AID/APOBEC enzymes, 
are shown on the left. Gels are shown without cropping in Supplementary Figure 2. (c) The 
fraction of deaminated substrates are plotted as a function of increasing concentrations of 
enzyme for mA1 and hAID-ΔC assayed against substrates containing a cytosine (magenta), 
mC (blue) or hmC (green). hAID-ΔC was incubated with the S30-TGX series of substrates, 
while mA1 was incubated with the S30-ATX substrates. Error bars represent standard 
deviation from the mean of at least three independent replicates. For relative comparison of 
substrates, the slope of each plot in the region where product formation is linear with 
enzyme (dashed line) is listed. The standard error for the measurement of enzyme dependent 
product formation is ±20% of the reported value for all measurements. The values given for 
hmC substrates are the lower limits of detection with these substrates.
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Figure 3. DNA deamination decreases as a function of increasing steric bulk at the 5-position of 
cytosine
(a) Schematic of the deamination assay with DNA oligonucleotides containing unnatural 
modifications at C5. (b) At left, the denaturing gel for hAID-ΔC with S30-TGX substrate 
series is shown. At right, the denaturing gel with mAPOBEC1 assayed against S30-ATX 
substrates. Samples were run in order of increasing steric bulk of the 5-substituent. Gels are 
shown without cropping in Supplementary Figure 7 (c) Shown are the electrostatic potential 
maps of each of the modified cytosine bases as determined using the SPARTAN program 
(6–31G* basis set). The electrostatic potential is colored from maximal negative (red) to 
positive (blue). The volume (*) is determined based on linking the 5-position substituent to a 
single hydrogen atom and calculating the total volume. The hydrophobic substituent 
constant (**) is derived from partitioning studies of substituted benzenes between octanol 
and water, where negative values for hydroxyl and hydroxymethyl substituents represent 
less hydrophobicity 33. Reported are the values for enzyme dependent product formation 
(nM product/μM enzyme) for each substrate examined with each active deaminases (†). The 
data for C, mC and hmC deamination are consolidated from Fig. 2c and Supplementary Fig. 
4; data for unnaturally modified substrates are consolidated from Supplementary Fig. 8. The 
relative activity for each modified substrate when compared to unmodified cytosine for each 
deaminase is reported parenthetically, allowing for comparisons across a row with each 
enzyme.
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Figure 4. AID/APOBEC enzymes do not perturb levels of mC oxidation intermediates in 
genomic DNA
(a) Genomic DNA was extracted from HEK 293T cells co-expressing TET2 along with an 
empty vector control, TDG, mA1 or hAID, digested to single nucleosides, and analyzed via 
mass spectrometry for the presence of C, mC, hmC, fC, caC, and hmU. The left axis depicts 
the absolute fmol of nucleoside on a logarithmic scale, while the right axis represents the 
approximate conversion from absolute fmol to the genomic prevalence of modified bases for 
every 105 dC bases. The dashed line demonstrates the lowest examined amount of fC, caC, 
and hmU standards. Error bars indicate the standard deviation from the mean for two to 
three biological replicates. Asterisks: p ≤ 10−3 for fC and caC in samples with TDG in 
comparison to plasmid only control. (b) To confirm that overexpressed hAID and mA1 are 
catalytically active, nuclear extracts were tested for deaminase activity against unmodified 
cytosine. At left, TET2-hAID nuclear extracts and negative controls (no extract, nuclear 
extract from untransfected 293T cells, and TET2-hAID E58A) were incubated with S30-
TGC substrate; At right, TET2-mA1 nuclear extracts and negative controls (no extract and 
nuclear extract from untransfected 293T cells) were incubated with S30-ATC substrate. The 
lanes demonstrating deamination of S30-TGC by TET2-hAID and S30-ATC substrate by 
TET2-mA1 extracts are highlighted (red). Nuclear extracts were also incubated with S30-
TGU or S30-ATU to verify robust uracil excision activity. Gels are shown without cropping 
in Supplementary Fig. 13.
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